Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Paclitaxel Cisplatin|DRUG: fluorouracil epirubicin cyclophosphamide and docetaxel (FEC-T)
Sponsor: Fudan University
Collaborators: Chinese Anti-Cancer Association